These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 17659942)
1. Prevention of renal dysfunction and hypertension by amlodipine after heart transplant. Leenen FH; Coletta E; Davies RA Am J Cardiol; 2007 Aug; 100(3):531-5. PubMed ID: 17659942 [TBL] [Abstract][Full Text] [Related]
2. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy. Ibrahim MM; el-Boghdadly B; Zaghloul SS J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565 [TBL] [Abstract][Full Text] [Related]
3. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367 [TBL] [Abstract][Full Text] [Related]
4. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension. Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS; Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192 [TBL] [Abstract][Full Text] [Related]
5. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study. Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z; Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787 [TBL] [Abstract][Full Text] [Related]
6. Enalapril/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial. Halimi JM; Giraudeau B; Buchler M; Al-Najjar A; Etienne I; Laouad I; Bruyère F; Lebranchu Y Clin Transplant; 2007; 21(2):277-84. PubMed ID: 17425758 [TBL] [Abstract][Full Text] [Related]
7. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial. Leonetti G; Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of amlodipine and diltiazem on 24-hour blood pressure, plasma catecholamines, and left ventricular mass. Leenen FH; Fourney A Am J Cardiol; 1996 Jul; 78(2):203-7. PubMed ID: 8712143 [TBL] [Abstract][Full Text] [Related]
9. Modifying effects of amlodipine on cyclosporin A-induced changes in renal function in patients with psoriasis. Raman GV; Campbell SK; Farrer A; Albano JD; Cook J J Hypertens Suppl; 1998 Sep; 16(4):S39-41. PubMed ID: 9817191 [TBL] [Abstract][Full Text] [Related]
10. A multicenter, randomized, double-blind, placebo-controlled, two-year trial to study the effect of nitrendipine on chronic renal transplant function. Barenbrock M; Colmorgen U; Firschka E; Gellert J; Lippert J; Schröder K; Spieker C; Voigt-Ladner G; Wagner K; Neumayer HH Clin Nephrol; 1995 Jun; 43(6):388-91. PubMed ID: 7554523 [TBL] [Abstract][Full Text] [Related]
11. A randomized, placebo-controlled trial of amlodipine in children with hypertension. Flynn JT; Newburger JW; Daniels SR; Sanders SP; Portman RJ; Hogg RJ; Saul JP; J Pediatr; 2004 Sep; 145(3):353-9. PubMed ID: 15343191 [TBL] [Abstract][Full Text] [Related]
12. Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients. Bunke M; Ganzel B J Heart Lung Transplant; 1992; 11(6):1194-9. PubMed ID: 1457446 [TBL] [Abstract][Full Text] [Related]
13. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension. Tsutamoto T; Tanaka T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M Hypertens Res; 2009 Aug; 32(8):670-4. PubMed ID: 19498438 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension]. Iskendeerov BG; Burmistrova LF; Berenshteĭn NV; Abramova GN; Lokhina TV; Shibaeva TM Klin Med (Mosk); 2006; 84(11):52-6. PubMed ID: 17243612 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3-5 chronic kidney disease. Abe M; Okada K; Maruyama T; Maruyama N; Matsumoto K Hypertens Res; 2009 Apr; 32(4):270-5. PubMed ID: 19262495 [TBL] [Abstract][Full Text] [Related]
16. An eight-week, multicenter, randomized, double-blind study to evaluate the efficacy and tolerability of fixed-dose amlodipine/benazepril combination in comparison with amlodipine as first-line therapy in chinese patients with mild to moderate hypertension. Ueng KC; Lin LC; Voon WC; Lin MC; Liu YB; Su HM; Chang PY; Lin TH; Chen WL; Wu CC; Lai WT; Lin CS Blood Press Suppl; 2008 Jun; 1():24-31. PubMed ID: 18705532 [TBL] [Abstract][Full Text] [Related]
17. Interactions of cyclosporin A and amlodipine: blood cyclosporin A levels, hypertension and kidney function. Schrama YC; Koomans HA J Hypertens Suppl; 1998 Sep; 16(4):S33-8. PubMed ID: 9817190 [TBL] [Abstract][Full Text] [Related]